About Cytox
Cytox is a Healthcare company based in Oxford (United Kingdom) founded in 2007. Prognostic tests for assessing dementia risk are developed. Cytox has raised $12.13 million across 8 funding rounds from investors including Gov.uk, Maven Capital Partners and Future Planet Capital Regional. The company has 12 employees. Its focus areas include Life Sciences, Clinical Genomics, Sequencing Based and Genetic Testing. Its legal entity is CYTOX LIMITED.
Company details
Cytox was founded in 2007 in Oxford, United Kingdom, within the biotechnology sector focused on diagnostics. SNP targets in the mTOR pathway are investigated to predict and diagnose mild cognitive impairment, recognized as an early stage of dementia and Alzheimers disease. Diagnostic approaches are provided through two products, genoSCORE LAB and genoTOR, which employ blood and saliva samples for risk assessment.
- Headquarters Oxford, United Kingdom
- Employees 12
- SectorsHealthcare
- Website cytoxgroup.com
- Social LinkedIn X
- Legal Name Cytox Limited
- Date of Incorporation 09 Jun, 2004
- Jurisdiction MANCHESTER
- Total Equity Funding$12.13M (USD)
in 8 rounds
- InvestorsGov.uk
& 14 more
- Employee Count12
Funding Insights of Cytox
Cytox has successfully raised a total of $12.13M across 8 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $12.13M
- Total Rounds 8
- First Round $1M
(Jun 2009)
- Investors Count 15
All 8 funding rounds of Cytox with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2019 | Series B | – | Maven Capital Partners | – | |
| May 2019 | $55,670 | Grant | – | – | |
| Feb 2019 | $65,450 | Grant | – | – | |
| Mar 2018 | $1.11M | Grant | – | – | |
| Jun 2017 | $3.3M | Series B | – | Catapult Ventures | |
| Apr 2014 | $2.5M | Series A | – | The North West Fund, Spark Impact | |
| May 2013 | $5.33M | Series A | – | – | – |
| Jun 2009 | $1M | Seed | – | – |
15 investors in total: 15 institutional.
Investors in Cytox
Cytox has secured backing from 15 investors, including venture fund and institutional investors. Prominent investors backing the company include Gov.uk, Maven Capital Partners and Future Planet Capital Regional.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Multiple sectors are targeted for private equity investments. | 2005 | mavencp.com | Birmingham, United Kingdom | |
Government agency and accelerator focusing on innovative startups and SMEs | eicfund.eu | Brussels, Belgium | ||
Investment solutions are provided by Catapult Ventures for growth. | catapult-ventures.com | Leicester, United Kingdom | ||
Early-stage innovations are funded by UKI2S across key sectors. | ukinnovationscienceseedfund.co.uk | Manchester, United Kingdom | ||
Venture capital funds are managed for life sciences and growth businesses. | gmclifesciencesfund.com | Enderby, United Kingdom | ||
Startups are incubated by Oxford University Innovation. | 1987 | innovation.ox.ac.uk | Oxford, United Kingdom | |
Venture debt firm | thenorthwestfund.co.uk | Warrington, United Kingdom | ||
Venture capital firm investing in seed & early-stage startups | wrencapital.co.uk | London, United Kingdom | ||
Venture debt is extended to UK life sciences companies. | 2011 | sparkimpact.co.uk | Chester, United Kingdom | |
Private equity investment firm | senecaeis.co.uk | Haydock, United Kingdom |
Investor details for Cytox
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Cytox
1 people are tracked at Cytox (1 in team); the tracked headcount is 12.
| Name | Role | Group |
|---|---|---|
Alex Gibson | Business Development And Strategic Partnerships | Team |
Complete people profiles for Cytox
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Cytox
3 dated milestones of Cytox across 12 years, from founding to its latest funding, stage changes and deals.
- Founded Cytox is founded.
- Funding First funding round of $1.0M.
- Funding Latest funding round, Series B,.
Top companies in Genomics & Gene Therapy Platforms
2 companies that operate in the same segment as Cytox (Genomics & Gene Therapy Platforms) in United Kingdom, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cytox
Complete news archive for Cytox
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cytox
Cytox was founded in 2007 and raised its 1st funding round 2 years after it was founded.
Cytox is headquartered in Oxford, United Kingdom. It is registered at Oxford, Oxfordshire, United Kingdom.
Cytox is a funded company, having raised a total of $12.13M across 8 funding rounds to date. The company's 1st funding round was a Seed of $1M, raised on Jun 2009.
Cytox has 12 employees.
Cytox was founded in 2007 in Oxford, United Kingdom, within the biotechnology sector focused on diagnostics. SNP targets in the mTOR pathway are investigated to predict and diagnose mild cognitive impairment, recognized as an early stage of dementia and Alzheimers disease. Diagnostic approaches are provided through two products, genoSCORE LAB and genoTOR, which employ blood and saliva samples for risk assessment.
Cytox has 15 investors. Key investors include Gov.uk, Maven Capital Partners, Future Planet Capital Regional, European Union, and Oxford University Innovation.
Cytox operates through Cytox Limited.